Diaz M, Quesada-Lopez T, Villarroya F, Casano P, Lopez-Bermejo A, de Zegher F
Int J Mol Sci. 2025; 26(4).
PMID: 40004184
PMC: 11854951.
DOI: 10.3390/ijms26041721.
Altamura S, Lombardi F, Palumbo P, Cinque B, Ferri C, Del Pinto R
Int J Mol Sci. 2025; 25(24.
PMID: 39769394
PMC: 11727698.
DOI: 10.3390/ijms252413633.
Wang H, Kim S, Lei Y, Wang S, Wang H, Huang H
Signal Transduct Target Ther. 2024; 9(1):235.
PMID: 39300084
PMC: 11415080.
DOI: 10.1038/s41392-024-01933-x.
Folgueira C, Herrera-Melle L, Lopez J, Galvan-Alvarez V, Martin-Rincon M, Cuartero M
Sci Adv. 2024; 10(33):eadn5993.
PMID: 39141732
PMC: 11323882.
DOI: 10.1126/sciadv.adn5993.
Xu C, Tai H, Chu Y, Liu Y, He J, Wang Y
Front Pharmacol. 2024; 15:1385330.
PMID: 38860164
PMC: 11163038.
DOI: 10.3389/fphar.2024.1385330.
Metabolic Dysfunction-Associated Steatohepatitis Detected by Neutrophilic Crown-Like Structures in Morbidly Obese Patients: A Multicenter and Clinicopathological Study.
Fan M, Song E, Zhang Y, Zhang P, Huang B, Yan K
Research (Wash D C). 2024; 7:0382.
PMID: 38812532
PMC: 11134285.
DOI: 10.34133/research.0382.
Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases.
Ng G, Loh Z, Fann D, Mallilankaraman K, Arumugam T, Hande M
Genome Integr. 2024; 15:e20230003.
PMID: 38770527
PMC: 11102075.
DOI: 10.14293/genint.14.1.004.
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences.
Samy A, Kandeil M, Sabry D, Abdel-Ghany A, Mahmoud M
Heliyon. 2024; 10(9):e30387.
PMID: 38737288
PMC: 11088336.
DOI: 10.1016/j.heliyon.2024.e30387.
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.
Nikolic I, Ruiz-Garrido I, Crespo M, Romero-Becerra R, Leiva-Vega L, Mora A
EMBO Rep. 2024; 25(6):2635-2661.
PMID: 38730210
PMC: 11169359.
DOI: 10.1038/s44319-024-00149-y.
Prepared Radix Polygoni Multiflori and emodin alleviate lipid droplet accumulation in nonalcoholic fatty liver disease through MAPK signaling pathway inhibition.
Huang C, Zhang Y, Xu Y, Wei S, Yang T, Wang S
Aging (Albany NY). 2024; 16(3):2362-2384.
PMID: 38284886
PMC: 10911387.
DOI: 10.18632/aging.205485.
Neutrophils in Physiology and Pathology.
Aroca-Crevillen A, Vicanolo T, Ovadia S, Hidalgo A
Annu Rev Pathol. 2024; 19:227-259.
PMID: 38265879
PMC: 11060889.
DOI: 10.1146/annurev-pathmechdis-051222-015009.
The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease.
Fa P, Ke B, Dupre A, Tsung A, Zhang H
Front Immunol. 2023; 14:1292679.
PMID: 38022519
PMC: 10652891.
DOI: 10.3389/fimmu.2023.1292679.
Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis.
Yang S, Zhang R, Deng W, Chang S, Li Y, Li S
Inflamm Res. 2023; 72(9):1773-1787.
PMID: 37659014
DOI: 10.1007/s00011-023-01776-2.
p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease.
Qi X, Chen G
Cells. 2023; 12(13).
PMID: 37443708
PMC: 10341180.
DOI: 10.3390/cells12131674.
The Influence of Sex Hormones in Liver Function and Disease.
Kasarinaite A, Sinton M, Saunders P, Hay D
Cells. 2023; 12(12).
PMID: 37371074
PMC: 10296738.
DOI: 10.3390/cells12121604.
Modified Signaling of Membrane Formyl Peptide Receptors in NADPH-Oxidase Regulation in Obesity-Resistant Mice.
Tikhonova I, Dyukina A, Shaykhutdinova E, Safronova V
Membranes (Basel). 2023; 13(3).
PMID: 36984693
PMC: 10058262.
DOI: 10.3390/membranes13030306.
Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking.
Li N, Liu H, Xue Y, Xu Z, Miao X, Guo Y
EMBO Mol Med. 2023; 15(3):e16592.
PMID: 36722664
PMC: 9994483.
DOI: 10.15252/emmm.202216592.
Advancements in MAFLD Modeling with Human Cell and Organoid Models.
Wang S, Yan J, Chan Y
Int J Mol Sci. 2022; 23(19).
PMID: 36233151
PMC: 9569457.
DOI: 10.3390/ijms231911850.
Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia.
Tong W, Ollivierre H, Noguchi A, Ghosh M, Springer D, Rouault T
Heliyon. 2022; 8(8):e10371.
PMID: 36061025
PMC: 9433723.
DOI: 10.1016/j.heliyon.2022.e10371.
Neutrophils in chronic inflammatory diseases.
Herrero-Cervera A, Soehnlein O, Kenne E
Cell Mol Immunol. 2022; 19(2):177-191.
PMID: 35039631
PMC: 8803838.
DOI: 10.1038/s41423-021-00832-3.